Technology
Yosi Albagli to continue as Ethernity Networks chairman
Data processing and networking semiconductor technology specialist Ethernity Networks announced the continuation of Joseph ‘Yosi’ Albagli's tenure as its non-executive chairman on Friday, following the conclusion of his initial three-year term.
SRT Marine pushes out year-end as it bids for new system contracts
Maritime surveillance and navigation technology specialist SRT Marine Systems announced a change to its financial reporting dates on Friday, in a bid to safeguard its ability to bid for pending new system contracts.
Physiomics revenue rises, losses narrow in first half
Physiomics reported revenue of £0. 37m in its interim results on Thursday, up from the £0. 34m it recorded a year earlier.
Nexxen reports mixed year amid ad market downturn
Advertising technology company Nexxen International reported a mixed financial performance in its full-year results on Wednesday, amid challenges in integrating the acquisition of Amobee, and a weaker overall advertising market.
Oxford Nanopore delays breakeven target as Covid revenue falls away
Molecular sensing technology developer Oxford Nanopore Technologies reported a fall in total revenue in its preliminary results for 2023 on Wednesday, despite a surge in life science research tool revenue, as it pushed out its forecast for reaching breakeven.
Oxford Biomedica shares rise on post-acquisition guidance
Shares in cell and gene therapy specialist Oxford Biomedica were jumping on Tuesday afternoon, after the company updated the market on its medium-term financial guidance.
DotDigital reports positive set of interim results
Customer experience and data platform (CDXP) provider dotDigital Group reported a positive set of interim results on Tuesday, with a 15% increase in group revenue to £38. 7m, and a solid 11% organic revenue increase excluding the acquisition of Fresh Relevance.
Fall in digital revenue drives weaker year for Reach
British media company Reach reported a 5. 4% decline in revenue in its annual results on Tuesday, to £568. 6m.
Ondine Biomedical assessing Steriwave with Yorkshire partners
Ondine Biomedical announced on Tuesday that it is joining forces with the Mid Yorkshire Teaching NHS Trust, Health Innovation Yorkshire and Humber, and the York Health Economics Consortium (YHEC) to assess the potential cost savings associated with using its ‘Steriwave’ technology.
XP Power revenue rises despite slower order intake
XP Power reported a 42% decrease in order intake in its annual results on Tuesday, to £208. 8m, while revenue saw a modest uptick of 9% to £316. 4m.
MaxCyte flags lower 2023 revenue, flat 2024 growth
Cell engineering technology specialist MaxCyte said in an update on Tuesday that it expected total 2023 revenue of between $41. 1m and $41. 3m, down from $44. 3m in 2022.
Braveheart to retain Paraytec after failing to find buyer
Braveheart Investment Group updated the market on one of its key investments, Paraytec, on Monday, confirming that it had failed to find an appropriate buyer for the company.
Rosslyn warns on revenue despite growing pipeline
Rosslyn Data Technologies warned on its revenue on Monday, even as it reported that since it announced its interim results on 25 January, it had seen a sustained expansion in its total pipeline, surpassing the figures recorded at the same time last year.
AFC Energy generator given the nod for CE mark
Hydrogen power generation technology company AFC Energy announced the reception of its first independent attestation of conformity certificate for a CE mark on Monday, from German certification agency TÜV SÜD for its 30kW H-Power S Series generator.
Mirriad finalises deal with major US media conglomerate
In-content advertising specialist Mirriad announced a significant two-year agreement with an unnamed major US media and entertainment conglomerate on Monday.
Craneware trading in line after first-half growth
US healthcare software and service specialist Craneware reported an 8% increase in first-half revenue in its interim results on Monday, to $91. 2m.
GlobalData confident after year of solid growth
Data, analytics and insights platform GlobalData reported a 12% rise in revenue in its full-year results on Monday, to £273. 1m, accompanied by a 32% increase in operating profit to £73. 7m.
Faron Pharmaceuticals shores up cash with EUR 3.2m convertible loans
Faron Pharmaceuticals announced on Monday that it has successfully secured binding commitments for convertible loans totalling €3. 2m from a select group of existing shareholders.
THG secures 17-month extension to revolving credit facility
THG announced the extension of its revolving credit facility (RCF) by 17 months on Monday, stretching its maturity to May 2026.
Hipgnosis Songs Fund asset value falls on independent review
Hipgnosis Songs Fund updated the market on ongoing strategic review on Monday, reporting a notable reduction in the company’s fair value after a detailed report from Shot Tower Capital.